System for administering biologically active substances produced by foaming techniques using compressed gases or supercritical fluids
A system for administering biologically active substances produced by foaming techniques using compressed gases or supercritical fluids relates to a porous system containing biologically active substances. The system includes a polymer matrix of poly(D,L-lactic-co-glycolic acid) or a polymer mixture containing poly(D,L-lactic-co-glycolic acid) of an intrinsic viscosity of less than 0.5 dL/g with other biodegradable synthetic or semisynthetic polyesters, a release-regulating component (starch and derivatives), and at least one biologically active substance. The matrix is biodegradable with a solid or semisolid consistency and a homogeneous appearance. A method for producing these systems using foaming with compressed fluids, and the use for the production of implants and scaffolds having this system are also disclosed. Optionally, a porogenic agent can be used for the formation of macropores by thermal decomposition.
1. A system for administering biologically active substances comprising a homogeneous biodegradable matrix with a solid or a semi-solid consistency having a porosity higher than 50% and less than or equal to 85%, said matrix comprises poly(D,L-lactic-co-glycolic acid), wherein said poly(D,L-lactic-co-glycolic acid) has an inherent viscosity less than 0.5 dL/g, pregelatinized starch at a proportion comprised between 0.1% and 25% by weight relative to said poly(D,L-lactic-co-glycolic acid), and poly(epsilon-caprolactone), and at least one biologically active substance selected from hormones, anti-inflammatory drugs, and morphogenic substances for bone defect repair, wherein said at least one biologically active substance is comprised at a proportion between 0.1 and 15% by weight with respect to poly(D,L-lactic-co-glycolic acid), wherein the poly(D,L-lactic-co-glycolic acid) and poly(epsilon-caprolactone) are present in 50:50 w/w ratios,
wherein the system for administering biologically active substances is obtained by a method including the following steps:
a) preparing a physical mixture comprising poly(D,L-lactic-co-glycolic acid) and a biologically active substance and, optionally a porogenic agent,
b) heating the mixture at a temperature equal to or less than 40° C.,
c) placing the mixture in contact with a compressed gas or supercritical fluid at a pressure between 40 bar and 120 bar and a temperature between 20° C. and 40° C. during a time period between 5 minutes and 24 hours, and
d) depressurization at a rate between 2 bar/min and 8 bar/min with cooling through the addition of a compressed liquid at a temperature between −196° C. and 19° C., the liquid being gaseous at 25° C. and 1 atmosphere of pressure.
2. A method of treating bone defects, reparing bone defects, and/or regenerating bone or cartilage in humans or animals comprising administering a pharmaceutical effective amount of a system as defined in claim 1 .